Revenue
2018
2019
2020
2021
2022
2023
2024
2025
Pharma-Bio Serv, Inc. (PBSV)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9.0M | $9.5M | $17.0M | $19.4M | $20.1M | $21.6M | $19.5M | $17.8M | $13.3M | — | — | — | — | — | — | — |
| Gross profit | $2.9M | $2.5M | $5.1M | $4.9M | $5.4M | $6.7M | $6.2M | $5.7M | $3.8M | $5.8M | $7.5M | $9.0M | $11.8M | $9.9M | $6.9M | $3.4M |
| Operating income | −$637,662 | −$1.3M | $1.1M | $1.2M | −$3.9M | $2.2M | $1.7M | −$1.3M | −$777,818 | −$91,759 | $1.8M | $2.9M | $6.1M | $5.7M | $3.5M | $609,890 |
| EBITDAderived | −$577,796 | −$1.3M | $1.2M | $1.2M | −$3.8M | $2.3M | $1.8M | −$1.2M | −$670,139 | $220,799 | $2.1M | $3.2M | $6.4M | $6.1M | $3.8M | $931,603 |
| Net income | −$100,463 | −$777,619 | $1.3M | $1.0M | −$2.1M | $2.1M | $2.1M | $1.3M | −$1.4M | −$256,575 | $1.6M | $2.4M | $4.9M | $4.7M | $3.2M | $371,911 |
| Basic EPSper diluted share | — | — | — | — | — | $0.09 | $0.09 | — | -$0.06 | -$0.01 | $0.07 | $0.11 | $0.22 | $0.23 | $0.15 | $0.02 |
| Diluted EPSper diluted share | -$0.00 | -$0.03 | $0.06 | — | — | $0.09 | $0.09 | — | -$0.06 | -$0.01 | $0.07 | $0.10 | $0.21 | $0.20 | $0.14 | $0.02 |